接种疫苗
经济评价
医学
季节性流感
干预(咨询)
流感疫苗
环境卫生
成本效益分析
经济分析
项目评估
成本效益分析
质量调整寿命年
甲型流感病毒
遗产管理(遗嘱认证法)
人口学
病毒学
控制(管理)
评价方法
流行病学
成本效益
作者
J R Pan,H Q He,X X Wang,S Y Wang,H J Zhang,X Deng,J M Sun
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-11-06
卷期号:60 (11): 1806-1809
标识
DOI:10.3760/cma.j.cn112150-20260108-00021
摘要
This study aimed to evaluate the cost-effectiveness of the seasonal influenza vaccination program for adults aged ≥60 years in Zhejiang Province, China, during the 2024-2025 influenza season from a societal perspective. The intervention strategy referred to the administration of one dose of trivalent inactivated influenza vaccine, while the control strategy assumed no influenza vaccination. Evaluation indicators included incremental cost-effectiveness ratio (ICER), incremental net monetary benefit (INMB) and benefit-cost ratio (B/C). With an ICER<1×per-capita GDP, INMB >0, or B/C ratio >1, the intervention strategy was considered cost-effective. Results showed that the intervention strategy with a 35% vaccination coverage rate was estimated to reduce influenza cases by 15.75% compared with the control strategy, yielding an incremental gain of 6 462 QALYs. The corresponding ICER, INMB and B/C were 4 751 CNY/QALY, 56.36 CNY and 4.93, respectively.
科研通智能强力驱动
Strongly Powered by AbleSci AI